Literature DB >> 19281796

Regulation of FOXO1-mediated transcription and cell proliferation by PARP-1.

Jun-ichi Sakamaki1, Hiroaki Daitoku, Kenji Yoshimochi, Masanao Miwa, Akiyoshi Fukamizu.   

Abstract

Forkhead box O (FOXO) transcription factors play an important role in a wide range of biological processes, including cell cycle control, apoptosis, detoxification of reactive oxygen species, and gluconeogenesis through regulation of gene expression. In this study, we demonstrated that PARP-1 functions as a negative regulator of FOXO1. We showed that PARP-1 directly binds to and poly(ADP-ribosyl)ates FOXO1 protein. PARP-1 represses FOXO1-mediated expression of cell cycle inhibitor p27(Kip1) gene. Notably, poly(ADP-ribosyl)ation activity was not required for the repressive effect of PARP-1 on FOXO1 function. Furthermore, knockdown of PARP-1 led to a decrease in cell proliferation in a manner dependent on FOXO1 function. Chromatin immunoprecipitation experiments confirmed that PARP-1 is recruited to the p27(Kip1) gene promoter through a binding to FOXO1. These results suggest that PARP-1 acts as a corepressor for FOXO1, which could play an important role in proper cell proliferation by regulating p27(Kip1) gene expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19281796     DOI: 10.1016/j.bbrc.2009.03.022

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  Transcriptional and post-transcriptional upregulation of p27 mediates growth inhibition of isorhapontigenin (ISO) on human bladder cancer cells.

Authors:  Guosong Jiang; Chao Huang; Jingxia Li; Haishan Huang; Jingjing Wang; Yawei Li; Fei Xie; Honglei Jin; Junlan Zhu; Chuanshu Huang
Journal:  Carcinogenesis       Date:  2018-03-08       Impact factor: 4.944

Review 2.  Forkhead followed by disordered tail: The intrinsically disordered regions of FOXO3a.

Authors:  Feng Wang; Christopher B Marshall; Mitsuhiko Ikura
Journal:  Intrinsically Disord Proteins       Date:  2015-06-03

Review 3.  Role of PARP-1 in prostate cancer.

Authors:  Dhanraj Deshmukh; Yun Qiu
Journal:  Am J Clin Exp Urol       Date:  2015-04-25

4.  PARP-2 regulates SIRT1 expression and whole-body energy expenditure.

Authors:  Péter Bai; Carles Canto; Attila Brunyánszki; Aline Huber; Magdolna Szántó; Yana Cen; Hiroyasu Yamamoto; Sander M Houten; Borbala Kiss; Hugues Oudart; Pál Gergely; Josiane Menissier-de Murcia; Valérie Schreiber; Anthony A Sauve; Johan Auwerx
Journal:  Cell Metab       Date:  2011-04-06       Impact factor: 27.287

5.  Non-transcriptional Function of FOXO1/DAF-16 Contributes to Translesion DNA Synthesis.

Authors:  Hiroaki Daitoku; Yuta Kaneko; Kenji Yoshimochi; Kaori Matsumoto; Sho Araoi; Jun-Ichi Sakamaki; Yuta Takahashi; Akiyoshi Fukamizu
Journal:  Mol Cell Biol       Date:  2016-08-22       Impact factor: 4.272

Review 6.  Cdc2: a monopotent or pluripotent CDK?

Authors:  X Hu; L C Moscinski
Journal:  Cell Prolif       Date:  2011-06       Impact factor: 6.831

7.  FOXO1A is a target for HER2-overexpressing breast tumors.

Authors:  Yanyuan Wu; Xiying Shang; Marianna Sarkissyan; Dennis Slamon; Jaydutt V Vadgama
Journal:  Cancer Res       Date:  2010-06-15       Impact factor: 12.701

8.  Absence of poly(ADP-ribose) polymerase 1 delays the onset of Salmonella enterica serovar Typhimurium-induced gut inflammation.

Authors:  Matthias Altmeyer; Manja Barthel; Matthias Eberhard; Hubert Rehrauer; Wolf-Dietrich Hardt; Michael O Hottiger
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

9.  PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy.

Authors:  Qian Li; Zhuo-Ming Li; Shu-Ya Sun; Lu-Ping Wang; Pan-Xia Wang; Zhen Guo; Han-Wei Yang; Jian-Tao Ye; Jing Lu; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2018-07-20       Impact factor: 6.150

10.  KRIT1 regulates the homeostasis of intracellular reactive oxygen species.

Authors:  Luca Goitre; Fiorella Balzac; Simona Degani; Paolo Degan; Saverio Marchi; Paolo Pinton; Saverio Francesco Retta
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.